Ulixertinib

  • Chemical Properties
CAS No. 869886-67-9 Cat. No. BCP04232
Name Ulixertinib
Synonyms 1956366-10-1; BVD-523; BVD 523; BVD523; VRT752271; VRT752271; VRT 752271;;
Formula C21H22Cl2N4O2 M. Wt 433.33
  • Biological Activity
Description Ulixertinib, also known as BVD-523 and VRT752271, is an inhibitors of ERK protein kinase. Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis. Upon oral administration, BVD-523 inhibits both ERK 1 and 2, thereby preventing the activation of ERK-mediated signal transduction pathways. This results in the inhibition of ERK-dependent tumor cell proliferation and survival. The mitogen-activated protein kinase (MAPK)/ERK pathway is often upregulated in a variety of tumor cell types and plays a key role in tumor cell proliferation, differentiation and survival.
Pathways MAPK Pathway 
Targets MEK/ERK 

Structure

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
Service & Tech Support:orders@biochempartner.com
Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.